A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
Clinical trial NCT05274659 · COMPLETED
Trial details
- NCT number
- NCT05274659
- Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2023-03-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.